| DESCRIPTION | - AKASHI ET AL., NATURE, (2000), vol. 404, no. 6774, page 193 |
| DESCRIPTION | - BULLINGER ET AL., BLOOD, (2008), vol. 111, pages 4490 - 4495 |
| DESCRIPTION | - CHEN ET AL., IMMUNOL REV, (1997), vol. 157, pages 41 - 51 |
| DESCRIPTION | - KONDO ET AL., ANNU REV IMMUNOL., (2003), vol. 21, pages 759 - 806 |
| DESCRIPTION | - KONDO ET AL., CELL, (1997), vol. 91, no. 5, pages 661 - 7 |
| DESCRIPTION | - MAJETI ET AL., CELL STEM CELL, (2007), vol. 1, pages 635 - 645 |
| DESCRIPTION | - MIKAYE K ET AL., J EXP MED, (1991), vol. 173, no. 3, pages 599 - 607 |
| DESCRIPTION | - MORRISON ET AL., CELL, (1999), vol. 96, pages 737 - 49 |
| DESCRIPTION | - MOTEGI S. ET AL., EMBO J., vol. 22, no. 11, pages 2634 - 2644 |
| DESCRIPTION | - SUBRAMANIAN ET AL., BLOOD, (2006), vol. 107, pages 2548 - 2556 |
| DESCRIPTION | - VALK ET AL., N ENGL J MED, (2004), vol. 350, pages 1617 - 1628 |
| DESCRIPTION | - WAGERS; WEISSMAN, STEM CELLS, (2006), vol. 24, no. 4, pages 1087 - 94 |
| DESCRIPTION | - WRIGHT DE ET AL., J EXP MED, (2002), vol. 195, no. 9, pages 1145 - 54 |
| OPPOSITION | - Anonymous, "A Study of IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory Lymphomas", ClinicalTrials.gov v Identifier: NCT04306224, (20200312), ClinicalTrials.gov v Identifier: NCT04306224, URL: https://classic.clinicaltrials.gov/ct2/show/NCT04306224?term=NCT04306224&draw=2&rank=1, (20231216), XP093112872 |
| OPPOSITION | - Anonymous, "Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers", ClinicalTrials.gov Identifier: NCT05192512, (20220114), ClinicalTrials.gov Identifier: NCT05192512, URL: https://classic.clinicaltrials.gov/ct2/show/NCT05192512?term=NCT05192512&draw=2&rank=1, (20231216), XP093112871 |
| OPPOSITION | - Anonymous, "Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors (PNOC025)", ClinicalTrials.gov Identifier: NCT05169944, (20211227), ClinicalTrials.gov Identifier: NCT05169944, URL: https://classic.clinicaltrials.gov/ct2/show/NCT05169944?term=NCT05169944&draw=2&rank=1, (20231216), XP093112873 |
| OPPOSITION | - Anonymous, "Scientists discover new way to distinguish self from other", Science Daily article, (20000619), XP055348264 |
| OPPOSITION | - Anonymous, "Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma (ELEVATE HNSCC)", Clinical Trials.gov Identifier: NCT04854499, (20210422), Clinical Trials.gov Identifier: NCT04854499, URL: https://classic.clinicaltrials.gov/ct2/show/NCT04854499, (20231216), XP093112868 |
| OPPOSITION | - Anonymous, "Study of Magrolimab Combination Therapy in Patients With Non-Surgically Removable Locally Advanced or Metastatic Triple-Negative Breast Cancer", Clinical Trials.gov Identifier: NCT04958785, (20210712), Clinical Trials.gov Identifier: NCT04958785, URL: https://clinicaltrials.gov/study/NCT04958785, (20231216), XP093112869 |
| OPPOSITION | - BONADONNA et al., "Textbook of Breast Cancer: A Clinical Guide to Therapy", Textbook of Breast Cancer: A Clinical Guide to Therapy, (20060000), page 81 |
| OPPOSITION | - CAMPBELL et al., "An Ovarian Tumor Marker with Homology to Vaccinia Virus Contains an IgV-like Region and Multiple Transmembrane Domains", Cancer Research, (19920000), vol. 52, pages 5416 - 5420, XP055348255 |
| OPPOSITION | - CAMPBELL et al., "An ovarian tumor marker with homology to vaccinia virus contains an IgV-like region and multiple transmembrane domains", Cancer Research, (19921001), vol. 52, pages 5416 - 5420, XP055348255 |
| OPPOSITION | - CAMPBELL, I. G. et al., "An ovarian tumor marker with homology to vaccinia virus contains an IgV-like region and multiple transmembrane domains", Cancer Research, (19920000), vol. 52, pages 5416 - 5420, XP055348255 |
| OPPOSITION | - CHAO et al., "TARGETING CD47 ELIMINATES HUMAN ACUTE MYELOID LEUKEMIA STEM CELLS", Meeting Abstract, Twenty- Fifth Annual Stanford Medical Student Research Symposium & Fifth Annual POM Population Health Symposium, (20080514), XP055348747 |
| OPPOSITION | - CHAO et al., "Targeting CD 47 eliminates human acute myeloid leukemia stem cells", Presentations at the Stanford Medical Student Research Symposium, (20080514), pages 1 - 7, XP055348747 |
| OPPOSITION | - CHRISTIANSEN et al., Mol. Cancer Ther., (20040000), vol. 3, pages 1493 - 1501, XP007901437 |
| OPPOSITION | - De Saint-Basile Genevieve, "Wiskott-Aldrich syndrome", Orphanet encyclopedia, (20030501), pages 1 - 4, XP093112870 |
| OPPOSITION | - FIDLER, "Inhibition of Pulmonary Metastasis by Intravenous Injection of Specifically Activated Macrophages1", Cancer Research, (19740000), vol. 34, pages 1074 - 1078, XP055674376 |
| OPPOSITION | - Hagmann, "A New Way to Keep Immune Cells in Check", Science, (20000616), vol. 288, no. 5473, pages 1945 - 1946, XP055345453 |
| OPPOSITION | - HAGMANN, A, "new way to keep immune cells in check", Science, (20000616), vol. 288, no. 5473, pages 1945 - 1946, XP055345453 |
| OPPOSITION | - "HL60", (20200106), wikipedia, URL: https://en.wikipedia.org/wiki/HL60, XP055673873 |
| OPPOSITION | - IDE et al., "Role for CD 47-SIRPa signaling in xenograft rejection by macrophages", PNAS, (20070320), vol. 104, no. 12, pages 5062 - 5066, XP055668087 |
| OPPOSITION | - JAMIESON et al., "Increased expression of CD47 is a constant marker in mouse and human myeloid leukemias", Blood, (20050000), vol. 106, no. 11, page 3260, XP008138745 |
| OPPOSITION | - KEY, "Macrophages in cancer metastases and their relevance to metastatic growth", Cancer and Metastasis Reviews, (19830000), vol. 2, pages 75 - 88 |
| OPPOSITION | - "L1210 cells", (06-10-2019), wikipedia, URL: https://en.wikipedia.org/wiki/L1210_cells, XP055673875 |
| OPPOSITION | - LATOUR et al., "Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation.", J Immunol, (20010000), vol. 167, pages 2547 - 2554, XP002457665 |
| OPPOSITION | - LATOUR et al., J. Immunology, (20010000), vol. 167, pages 2547 - 2554, XP002457665 |
| OPPOSITION | - MAJETI et al., "CD 47 is an independent prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells", Blood, (20081116), vol. 112, no. 11, page 284, XP009160228 |
| OPPOSITION | - MAJETI et al., "CD47 Is An Independent Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells", Blood : journal of the American Society of Hematology, (20080000), vol. 112, page 284, XP009160228 |
| OPPOSITION | - Majeti Ravindra et al, "CD47 Is An Independent Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells", Blood , US, (20081101), vol. 112, no. 11, ISSN 0006-4971, page 284, XP009160228 |
| OPPOSITION | - MAJETI, R . et al., "CD 47 is an independent prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells", Blood, (20080000), vol. 112, no. 2, page 284, XP009160228 |
| OPPOSITION | - MAWBY et al., "Isolation and characterization of CD 47 glycoprotein: a 1 December 1994", BIOCHEM, (19990000), vol. 304, pages 525 - 530, XP008037597 |
| OPPOSITION | - NOMURA et al., Humanized Mice, (20080000), pages 53 - 76 |
| OPPOSITION | - OLDENBORG et al., "Cd47-Signal Regulatory Protein α (Sirpα) Regulates Fcγ and Complement Receptor-Mediated Phagocytosis", J. Exp. Med., (20010000), vol. 193, no. 7, pages 855 - 861, XP055283803 |
| OPPOSITION | - OLDENBORG et al., "Cd47-Signal Regulatory Protein α (Sirpα) Regulates Fcγ and Complement Receptor-Mediated Phagocytosis", Journal of Experimental Medicine, (20010402), vol. 193, no. 7, pages 855 - 862, XP055283803 |
| OPPOSITION | - OLDENBORG P-A. et al., "Cd47-Signal Regulatory Protein α (Sirpα) Regulates Fcγ and Complement Receptor-Mediated Phagocytosis", J. Exp. Med., (20010000), vol. 193, no. 7, pages 855 - 862, XP055283803 |
| OPPOSITION | - Per-Arne Oldenborg et al, "Cd47-Signal Regulatory Protein α (Sirpα) Regulates Fcγ and Complement Receptor-Mediated Phagocytosis", The Journal of Experimental Medicine, vol. 193, no. 7, pages 855 - 861, The Journal of Experimental Medicine, URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193364/pdf/010027.pdf, (20160627), XP055283803 |
| OPPOSITION | - PETTERSEN et al., "CD47 Signals T Cell Death", J Immunol, (19990000), vol. 162, pages 7031 - 7040, XP002942113 |
| OPPOSITION | - PETTERSEN et al., J. Immunology, (19990000), vol. 162, pages 7031 - 7040, XP002940659 |
| OPPOSITION | - POELS et al., "Monoclonal Antibody Against Human Ovarian Tumor-Associated Antigens", Journal of the National Cancer Institute, (19860000), vol. 76, no. 5, pages 781 - 791, XP055663185 |
| OPPOSITION | - POELS, L. G. et al., "Monoclonal Antibody Against Human Ovarian Tumor-Associated Antigens", J. Natl. Cancer Inst., (19860000), vol. 76, no. 5, pages 781 - 791, XP055663185 |
| OPPOSITION | - REBRES et al., "Novel CD 47-dependent intercellular adhesion modulates cell migration", Journal of Cellular Physiology, (20050505), vol. 205, no. 2, pages 182 - 193, XP055345445 |
| OPPOSITION | - Rebres et al, "Novel CD47-Dependent lntercellular Adhesion Modulates Cell Migration", J. Cell. Physiol., (20050101), vol. 205, pages 182 - 193, XP055345445 |
| OPPOSITION | - Rutger H., Et Al., "Students draw a crowd to annual research and community health symposium", News release from Stanford School of Medicine, (20080521), pages 1 - 5, XP055532055 |
| OPPOSITION | - RUTQER, "Students draw a crowd to annual research and community health symposium", Medical Center Report, XP055532055 |
| OPPOSITION | - "Scientists Discover New Way To Distinguish Self From Other", Science Daily, (20000619), XP055348264 |
| OPPOSITION | - SEIFFERT et al., Blood, (19990000), vol. 94, pages 3633 - 3643, XP000984772 |
| OPPOSITION | - SEIFFERT et al., "Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47", Blood, (19990000), vol. 94, no. 11, pages 3633 - 3643, XP000984772 |
| OPPOSITION | - SEIFFERT et al., "Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD 47", Blood, (19991201), vol. 94, no. 11, pages 3633 - 3643, XP000984772 |
| OPPOSITION | - SINGH et al., "Chapter 6", Bone Metastasis and Molecular Mechanisms: Pathophysiology, (20040000), pages 87 - 108, XP055674382 |
| OPPOSITION | - TEICHER, "Antiangiogenic Agents in Cancer Therapy", Antiangiogenic Agents in Cancer Therapy, (19990000), pages 185 - 203 |
| OPPOSITION | - TUZMAN, "Eat this, don't eat that: CD 47 companies", Biocentury, (20190000), XP55673996 |
| OPPOSITION | - UCHENDU et al., "Preliminary study on the role of protein kinase C in CD 47-mediated phosphatidylserine exposure pathway by Bric 126 in Jurkat T Cells", Der Pharmacia Lettre, (20170913), vol. 9, no. 8, pages 18 - 28, XP055668186 |
| OPPOSITION | - VERNON-WILSON et al., "CD47 IS A LIGAND FOR RAT MACROPHAGE MEMBRANE SIGNAL REGULATORY PROTEIN SIRP (OX41) AND HUMAN SIRPALPHA1", Eur. J. Immunol., (20000000), vol. 30, pages 2130 - 2137, XP000984773 |
| OPPOSITION | - VERNON-WILSON et al., Eur J Immunol, (20000000), vol. 30, pages 2130 - 2137, XP000984773 |
| OPPOSITION | - WEISKOPF et al., "Engineered SIRP alpha Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies", Science, (20130000), vol. 341, pages 88 - 91, XP002769489 |
| OPPOSITION | - YOSHIDA et al., "Interaction between Src homology 2 domain bearing protein tyrosine phosphatase substrate-1 and CD 47 mediates the adhesion of human B lymphocytes to nonactivated endothelial cells", J Immunol, (20020401), vol. 168, pages 3213 - 3220, XP002423402 |
| OPPOSITION | - ZHANG et al., "Targeting the cancer biomarker CD 47: a review on the diverse mechanisms of the CD 47 pathway in cancer treatment", Anti-Cancer Agents in Medicinal Chemistry, (20160000), vol. 16, no. 6, pages 658 - 667, XP055668169 |
| OPPOSITION | - PFEIFFER et al., "Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts", Eur. J. Immunol., (20010000), vol. 31, pages 3153 - 3164, XP055541184 |
| OPPOSITION | - RAETZ et al., Pediatr Blood Cancer, (20060000), vol. 47, pages 130 - 140, XP055348724 |
| OPPOSITION | - Narla Rama Krishna; Modi Hardik; Bauer Daniel; Abbasian Mahan; Leisten Jim; Piccotti Joseph R.; Kopytek Stephan; Eckelman Brendan P.; Deveraux Quinn; Timmer John; Zhu Dan; Wong Lilly; Escoubet Laure; Raymon Heather K.; Hariharan Kandasamy, "Modulation of CD47-SIRPα innate immune checkpoint axis with Fc-function detuned anti-CD47 therapeutic antibody", Cancer immunology immunotherapy, Springer, Berlin/Heidelberg, Berlin/Heidelberg , (20210710), vol. 71, no. 2, doi:10.1007/s00262-021-03010-6, ISSN 0340-7004, pages 473 - 489, XP037673283 |
| OPPOSITION | - WEISSMAN, I. L., "The E. Donnall Thomas Lecture: Normal and Neoplastic Stem Cells", Biology of Blood and Marrow Transplantation, (20080000), vol. 14, pages 849 - 858, XP022940656 |
| OPPOSITION | - KIKUCHI, Y. et al., "A bivalent single-chain Fv fragment against CD47 induces apoptosis for leukemic cells", Biochem. Biophys. Res. Commun., (20040000), vol. 315, pages 912 - 918, XP004491573 |
| OPPOSITION | - OLSSON, M. et al., "Dose-dependent inhibitory effect of CD47 in macrophage uptake of IgG-opsonized murine erythrocytes", Biochem. Biophys. Res. Comm., (20070000), vol. 352, pages 193 - 197, XP005724581 |
| OPPOSITION | - GARDAI et al., "Cell-surface calreticulin initiates clearance of viable apoptotic cells through trans-activation of LRP on the phagocyte", Cell, (20050000), vol. 123, pages 321 - 334, XP002432361 |
| OPPOSITION | - GARDAI et al., "Cell -surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte", Cell, (20051021), vol. 123, doi:10.1016/j.cell.2005.08.032, pages 321 - 334, XP002432361 |
| OPPOSITION | - GARDAI S.J, ET AL, "Cell-surface calreticulin initiates clearance of viable apoptotic cells through trans-activation of LRP on the phagocyte.", CELL, ELSEVIER, AMSTERDAM, NL, (20051021), vol. 123, doi:10.1016/j.cell.2005.08.032, ISSN 0092-8674, pages 321 - 334, XP002432361 |
| OPPOSITION | - GARDAI, S. J. et al., "Cell -surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte", Cell, (20050000), vol. 123, no. 2, pages 321 - 334, XP002432361 |
| OPPOSITION | - CONGOTE et al., "The C-terminal 26-residue peptide of serpin A1 stimulates proliferation of breast and liver cancer cells: role of protein kinase C and CD47", FEBS Letters, (20040000), vol. 576, pages 343 - 347, XP004605712 |
| OPPOSITION | - VAN DEN BERG et al., Trends Immunol., (20080000), vol. 29, pages 203 - 206, XP022635428 |
| OPPOSITION | - VAN DEN BERG, T. K. et al., "Innate immune 'self' recognition: a role for CD47-SIRP@a interactions in hematopoietic stem cell transplantation", Trends In Immunology, (20080000), vol. 29, no. 5, pages 203 - 206, XP022635428 |
| OPPOSITION | - OLSSON et al., "Target cell CD 47 regulates macrophage activation and erythrophagocytosis", Transfusion Clinique et biologique, (20060329), vol. 13, no. 1- 2, doi:10.1016/j.tracli.2006.02.013, pages 39 - 43, XP028032798 |
| OPPOSITION | - Peter M. Henson et al, "Apoptotic cell removal", CURRENT BIOLOGY, GB, (20011001), vol. 11, no. 19, doi:10.1016/S0960-9822(01)00474-2, ISSN 0960-9822, pages R795 - R805, XP055348314 |
| OPPOSITION | - BROWN et al., "Integrin-associated protein (CD47) and its ligands", Trends in Cell Biology, (20010000), vol. 11, no. 3, pages 130 - 135, XP002413983 |
| OPPOSITION | - BROWN et al., "Integrin-associated protein ( CD 47) and its ligands", Trends in Cell Biology, (20010301), vol. 11, no. 3, doi:10.1016/S0962-8924(00)01906-1, pages 130 - 135, XP002413983 |
| OPPOSITION | - BROWN et al., Trends in Cell Biol., (20010000), vol. 11, pages 130 - 135, XP002413983 |
| OPPOSITION | - PLATT, N. et al., "Recognizing death: the phagocytosis of apoptotic cells", Trends in Cell Biology, (19980000), vol. 8, pages 365 - 372, XP055673783 |
| OPPOSITION | - Wang Yuchen, Zhao Chenxuan, Liu Yang, Wang Chao, Jiang Haojie, Hu Yiqiao, Wu Jinhui, "Recent Advances of Tumor Therapy Based on the CD47-SIRPα Axis", Molecular Pharmaceutics, American Chemical Society, US, US , (20220502), vol. 19, no. 5, doi:10.1021/acs.molpharmaceut.2c00073, ISSN 1543-8384, pages 1273 - 1293, XP093078337 |
| OPPOSITION | - MATEO et al., "CD47 LIGATION INDUCES CASPASE-INDEPENDENT CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA", Nature Medicine, (19990000), vol. 5, no. 11, pages 1277 - 1284, XP002942112 |
| OPPOSITION | - MATEO et al., "CD 47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia", Nature Medicine, (19991100), vol. 5, no. 11, doi:10.1038/15233, pages 1277 - 1284, XP002942112 |
| OPPOSITION | - MATEO, V. et al., "CD 47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia", Nature Medicine, (19990000), vol. 5, no. 11, pages 1277 - 1284, XP002942112 |
| OPPOSITION | - MATEO V ET AL, "CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia.", Nature Medicine, New York, (19991101), vol. 5, no. 11, doi:10.1038/15233, ISSN 1078-8956, pages 1277 - 1284, XP002163073 |
| OPPOSITION | - PIETSCH, E. C. et al., "Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies", Blood Cancer Journal, (20170000), vol. 7, page e536, XP055395279 |
| OPPOSITION | - PIETSCH et al., "Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies", Blood Cancer Journal, (20170000), vol. 7, pages 1 - 8, XP055395279 |
| OPPOSITION | - PIETSCH et al., Blood Cancer Journal, (20170000), vol. 7, page e536, XP055538876 |
| OPPOSITION | - LIOTTA et al., "REDUCTION OF TUMOUR CELL ENTRY INTO VESSELS BY BCG-ACTIVATED MACROPHAGES", Br. J. Cancer, (19770000), vol. 36, pages 639 - 641, XP055674374 |
| OPPOSITION | - JONES et al., "Immunological mechanisms in metastatic spread and the antimetastatic effects of C. parvum", Br. J. Cancer, (19770000), vol. 35, pages 519 - 527, XP055674367 |
| OPPOSITION | - G Kroemer et al, "Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009", CELL DEATH AND DIFFERENTIATION, GB, (20090101), vol. 16, no. 1, doi:10.1038/cdd.2008.150, ISSN 1350-9047, pages 3 - 11, XP055348325 |
| OPPOSITION | - TAKIZAWA et al., "Macrophage tolerance: CD 47-SIRP-a-mediated signals matter", Nature Immunology, (20071200), vol. 8, no. 12, doi:10.1038/ni1207-1287, pages 1287 - 1289, XP055094296 |
| OPPOSITION | - TAKIZAWA et al., Nature Immunol., (20070000), vol. 8, pages 1287 - 1289, XP055094296 |
| OPPOSITION | - TAKIZAWA, H. et al., "Macrophage tolerance: CD 47-SIRP-a-mediated signals matter", Nature Immunol, (20070000), vol. 8, pages 1287 - 1289, XP055094296 |
| OPPOSITION | - TAKENAKA et al., "Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells", Nature Immunol, (20071200), vol. 8, no. 12, doi:10.1038/ni1527, pages 1313 - 1323, XP055539168 |
| OPPOSITION | - Liu Yu’e, Wang Yanjin, Yang Yanrong, Weng Linjun, Wu Qi, Zhang Jin, Zhao Pengcheng, Fang Lan, Shi Yufeng, Wang Ping, "Emerging phagocytosis checkpoints in cancer immunotherapy", Signal Transduction and targeted Therapy, (20230307), vol. 8, no. 1, doi:10.1038/s41392-023-01365-z, ISSN 2059-3635, pages 1 - 42, XP093108444 |
| OPPOSITION | - ZHANG et al., Cell Research, (20070000), vol. 17, pages 89 - 99, XP55674003 |
| OPPOSITION | - MATSUO et al., "Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins (11;9) (q23;p22p23)", Leukemia, (19970000), vol. 11, pages 1469 - 1477, XP009502888 |
| OPPOSITION | - Ozols Robert F, "Systemic therapy for ovarian cancer: current status and new treatments.", SEMINARS IN ONCOLOGY, W.B. SAUNDERS, US, US , (20060401), vol. 33, no. 2 Sppl. 6, doi:10.1053/j.seminoncol.2006.03.011, ISSN 0093-7754, pages S3 - S11, XP009148909 |
| OPPOSITION | - GOSSEN et al., "TIGHT CONTROL OF GENE EXPRESSION IN MAMMALIAN CELLS BY TETRACYCLINE-RESPONSIVE PROMOTERS", Proc. Natl. Acad. Sci. USA ., (19920000), vol. 89, no. 12, pages 5547 - 5551, XP000564458 |
| OPPOSITION | - GAO et al., "Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin", The Journal of Biological Chemistry, (19960000), vol. 271, no. 1, pages 21 - 24, XP002248145 |
| OPPOSITION | - LIU et al., "The Role of CD47 in Neutrophil Transmigration : INCREASED RATE OF MIGRATION CORRELATES WITH INCREASED CELL SURFACE EXPRESSION OF CD47", The Journal of Biological Chemistry, (20010000), vol. 276, no. 43, pages 40156 - 40166, XP055674346 |
| OPPOSITION | - LIU et al., "Signal Regulatory Protein (SIRPalpha ), a Cellular Ligand for CD47, Regulates Neutrophil Transmigration", The Journal of Bioloqical Chemistry, (20020000), vol. 277, no. 12, pages 10028 - 10036, XP055030073 |
| OPPOSITION | - LIU, Y. et al., "Signal Regulatory Protein (SIRPalpha ), a Cellular Ligand for CD47, Regulates Neutrophil Transmigration"", J. Biol. Chem., (20020000), vol. 277, no. 12, pages 10028 - 10036, XP055030073 |
| OPPOSITION | - Y. Liu et al, "Signal Regulatory Protein (SIRPalpha ), a Cellular Ligand for CD47, Regulates Neutrophil Transmigration", Journal of Biological Chemistry, (20020315), vol. 277, no. 12, doi:10.1074/jbc.M109720200, ISSN 00219258, pages 10028 - 10036, XP055030073 |
| OPPOSITION | - BARAZI et al., Journal of Biological Chemistry, (20020000), vol. 277, no. 45, pages 42859 - 42866, XP002468585 |
| OPPOSITION | - OLDENBORG et al., Leukemia & Lymphoma, (20040000), vol. 45, pages 1319 - 1327, XP008060559 |
| OPPOSITION | - OLDENBORG, P-A. et al., "Role of CD 47 in erythroid cells and in autoimmunity", Leukemia & Lymphoma, (20040000), vol. 45, no. 7, pages 1319 - 1327, XP008060559 |
| OPPOSITION | - OLDENBORG, "Role of CD 47 in erythroid cells and in autoimmunity", Leukemia and Lymphoma, (20040700), vol. 45, no. 7, doi:10.1080/1042819042000201989, pages 1319 - 1327, XP008060559 |
| OPPOSITION | - OLDENBORG, "ROLE OF CD47 IN ERYTHROID CELLS AND IN AUTOIMMUNITY", Leukemia & Lymphoma, (20040000), vol. 45, no. 7, pages 1319 - 1327, XP008060559 |
| OPPOSITION | - RUSSEL et al., "Functional characterization of a stable, noncytolytic stage of macrophage activation in tumors.", The Journal of Experimental Medicine, (19770000), vol. 146, pages 1511 - 1520, XP055674372 |
| OPPOSITION | - ARMANT et al., "CD47 LIGATION SELECTIVELY DOWNREGULATES HUMAN INTERLEUKIN 12 PRODUCTION", J. Exp. Med., (19990000), vol. 190, no. 8, pages 1175 - 1181, XP000984762 |
| OPPOSITION | - BLAZAR, B. R. et al., "Integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells", J. Exp. Med., (20010000), vol. 194, no. 4, pages 541 - 549, XP055084225 |
| OPPOSITION | - BLAZAR et al., "Integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells", Journal of Experimental Medicine, vol. 194, no. 4, (20010820), pages 541 - 549, XP055084225 |
| OPPOSITION | - BLAZAR et al., J. Exp. Medicine, (20010000), vol. 194, pages 541 - 549, XP055084225 |
| OPPOSITION | - Kaur Sukhbir, Cicalese Kyle V, Banerjee Rajdeep, Roberts David D, "Preclinical and clinical development of therapeutic antibodies targeting functions of CD47 in the tumor microenvironment", Antibody Therapeutics, (20200725), vol. 3, no. 3, doi:10.1093/abt/tbaa017, pages 179 - 192, XP055805185 |
| OPPOSITION | - Takimoto C.H., Chao M.P., Gibbs C., Mccamish M.A., Liu J., Chen J.Y., Majeti R., Weissman I.L., "The Macrophage ‘Do not eat me’ signal, CD47, is a clinically validated cancer immunotherapy target", Annals of Oncology, (20190301), vol. 30, no. 3, doi:10.1093/annonc/mdz006, ISSN 0923-7534, pages 486 - 489, XP093108437 |
| OPPOSITION | - MOTEGI et al., "Role of the CD 47-SHPS-1 system in regulation of cell migration", The EBMO Journal, (20030602), vol. 22, no. 11, doi:10.1093/emboj/cdg278, pages 2634 - 2644, XP002481062 |
| OPPOSITION | - CROKER et al., "Cancer stem cells: implications for the progression and treatment of metastatic disease", J. Cell . Mol. Med., (20071220), vol. 12, no. 2, pages 374 - 390, XP055668069 |
| OPPOSITION | - WEISKOPF et al., Science, (20130000), vol. 341, pages 88 - 91, XP002745510 |
| OPPOSITION | - OLDENBORG et al., "Role of CD47 as a Marker of Self on Red Blood Cells", Science, (20000000), vol. 288, pages 2051 - 2054, XP055304810 |
| OPPOSITION | - OLDENBORG et al., "Role of CD 47 as a marker of self on red blood cells", Science, (20000616), vol. 288, doi:10.1126/science.288.5473.2051, pages 2051 - 2054, XP055304810 |
| OPPOSITION | - OLDENBORG, P-A. et al., "Role of CD 47 as a marker of self on red blood cells", Science, (20000000), vol. 288, no. 5473, pages 2051 - 2054, XP055304810 |
| OPPOSITION | - P.-A. Oldenborg, "Role of CD47 as a Marker of Self on Red Blood Cells", Science, US, (20000616), vol. 288, no. 5473, doi:10.1126/science.288.5473.2051, ISSN 0036-8075, pages 2051 - 2054, XP055304810 |
| OPPOSITION | - MANNA et al., "CD47 mediates killing of breast tumor cells via Gi-dependent inhibition of protein kinase A.", Cancer Research, (20040000), vol. 64, pages 1026 - 1036, XP055030076 |
| OPPOSITION | - MANNA et al., "CD 47 mediates killing of breast tumor cells via Gi- dependent inhibition of protein kinase A", Cancer Research, (20040201), vol. 64, doi:10.1158/0008-5472.CAN-03-1708, pages 1026 - 1036, XP055030076 |
| OPPOSITION | - Partha Manna, William Frazier, "CD47 mediates killing of breast tumor cells via Gi-dependent inhibition of protein kinase A.", Cancer research, (20040201), vol. 64, no. 3, doi:10.1158/0008-5472.CAN-03-1708, ISSN 00085472, pages 1026 - 1036, XP055030076 |
| OPPOSITION | - CHEN et al., "Expression and activation of signal regulatory protein a on astrocytomas", Cancer Research, (20040101), vol. 64, doi:10.1158/0008-5472.CAN-3455-2, pages 117 - 127, XP055348732 |
| OPPOSITION | - TAMOTO et al., "Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer", Clin Cancer Res., (20040601), vol. 10, pages 3629 - 3638, XP055668078 |
| OPPOSITION | - PETROVA, P. S. et al., "TI - TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding", Clin. Cancer Res., (20170000), vol. 23, no. 4, pages 1068 - 1079, XP055540513 |
| OPPOSITION | - KIM et al., "Association of CD 47 with natural killer cell -mediated cytotoxicity of head-and-neck squamous cell carcinoma lines", Tumor Biology, (20080500), vol. 29, pages 28 - 34, XP055347764 |
| OPPOSITION | - WEISKOPF et al., "CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer", The Journal of Clinical Investigation, (20160000), vol. 126, no. 7, pages 2610 - 2620, XP055480649 |
| OPPOSITION | - WEISKOPF et al., J Clin Invest., (20160000), vol. 126, no. 7, pages 2610 - 2620, XP055480649 |
| OPPOSITION | - ITO et al., "NOD/SCID/GAMMAcnull mouse: an excellent recipient mouse model for engraftment of human cells", Blood, (20020000), vol. 100, no. 9, pages 3175 - 3182, XP002981771 |
| OPPOSITION | - MATEO et al., "Mechanisms of CD 47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organisation", Blood, (20020614), vol. 100, no. 8, doi:10.1182/blood-2001-12-0217, pages 2882 - 2890, XP055125010 |
| OPPOSITION | - MATEO et al., "Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization", Blood, (20020000), vol. 100, no. 8, pages 2882 - 2890, XP055125010 |
| OPPOSITION | - V. Mateo et al, "Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization", Blood, (20020926), vol. 100, no. 8, doi:10.1182/blood-2001-12-0217, ISSN 00064971, pages 2882 - 2890, XP055125010 |
| OPPOSITION | - OLSSON et al., Blood, (20050000), vol. 105, pages 3577 - 3582, XP055347748 |
| OPPOSITION | - OLSSON et al., "Platelet homeostasis is regulated by platelet expression of CD 47 under normal conditions and in passive immune thrombocytopenia", Blood, (20050501), vol. 105, no. 9, doi:10.1182/blood-2004-08-2980, pages 3577 - 3582, XP055347748 |
| OPPOSITION | - OLSSON, M. et al., "Platelet homeostasis is regulated by platelet expression of CD 47 under normal conditions and in passive immune thrombocytopenia", Blood, (20050000), vol. 105, no. 9, pages 3577 - 3582, XP055347748 |
| OPPOSITION | - SUBRAMANIAN et al., Blood, (20060000), vol. 107, pages 2548 - 2556, XP002608759 |
| OPPOSITION | - SUBRAMANIAN et al., "Species- and cell type-specific interactions between CD 47 and human SIRPa", Blood, (20051115), vol. 107, no. 6, doi:10.1182/blood-2005-04-1463, pages 2548 - 2556, XP002608759 |
| OPPOSITION | - SUBRAMANIAN et al., "Species- and cell type-specific interactions between CD47 and human SIRP[alpha]", Blood, (20060000), vol. 107, no. 6, pages 2548 - 2556, XP002608759 |
| OPPOSITION | - WANG et al., Blood, (20070000), vol. 109, pages 836 - 842, XP002608757 |
| OPPOSITION | - WANQ et al., "Attenuation of phagocytosis of xenogeneic cells by manipulating CD47", Blood, (20070000), vol. 109, no. 2, doi:10.1182/blood-2006-04-019794, pages 836 - 842, XP002608757 |
| OPPOSITION | - ZHAO et al., Blood, (20120000), vol. 119, pages 4333 - 4335, XP055116565 |
| OPPOSITION | - Jamieson et al, "Increased expression of CD 47 is a constant marker in mouse and human myeloid leukemias", Blood, (20051116), vol. 106, no. 11, pages 1 - 5, XP055668075 |
| OPPOSITION | - JAMIESON et al., "Increased expression of CD 47 is a constant marker in mouse and human myeloid leukemias", Blood, (20051116), vol. 106, no. 11, pages 1 - 5, XP055668075 |
| OPPOSITION | - OLDENBORQ et al., "Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice", Blood, (20020000), vol. 99, no. 10, pages 3500 - 3504, XP055674279 |
| OPPOSITION | - Liu Mengmeng, Liu Lina, Song Yongping, Li Wei, Xu Linping, "Targeting macrophages: a novel treatment strategy in solid tumors", Journal of Translational Medicine, (20221212), vol. 20, no. 1, doi:10.1186/s12967-022-03813-w, page 586, XP093112866 |
| OPPOSITION | - Qu Tailong, Li Baiyong, Wang Yifei, "Targeting CD47/SIRP[alpha] as a therapeutic strategy, where we are and where we are headed", Biomarker research, BioMed Central Ltd, (20220413), vol. 10, doi:10.1186/s40364-022-00373-5, pages 1 - 18, XP093028950 |
| OPPOSITION | - TROUNSON, "Stem cells, plasticity and cancer - uncomfortable bed fellows", Development, (20040600), vol. 131, no. 12, doi:10.1242/dev.01233, pages 2763 - 2768, XP055348759 |
| OPPOSITION | - KAUDER, S. E. et al., "ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile", PLOS one, (20180000), vol. 13, no. 8, page e0201832, XP055635503 |
| OPPOSITION | - Reardon David A., Wen Patrick Y., "Therapeutic Advances in the Treatment of Glioblastoma: Rationale and Potential Role of Targeted Agents", THE ONCOLOGIST, (20060201), vol. 11, no. 2, doi:10.1634/theoncologist.11-2-152, ISSN 1083-7159, pages 152 - 164, XP093112867 |
| OPPOSITION | - STROME et al., "A Mechanistic Perspective of Monoclonal Antibodies in Cancer Therapy Beyond Target-Related Effects", The Oncologist, (20070000), vol. 12, pages 1084 - 1095, XP055052443 |
| OPPOSITION | - STROME et al., "A mechanistic perspective of monoclonal antibodies in cancer therapy beyond target-related effects", The Oncologist, (20070900), vol. 12, doi:10.1634/theoncologist.12-9-1084, pages 1084 - 1095, XP055052443 |
| OPPOSITION | - METAYER et al., "Anti-CD47 antibodies induce phagocytosis of live, malignant B cells by macrophages via the Fc domain, resulting in cell death by phagoptosis", Oncotarget, (20170000), vol. 8, no. 3 7, pages 60892 - 60903, XP055456424 |
| OPPOSITION | - METAYER et al., Oncotarget, (20170000), vol. 8, no. 37, pages 60892 - 60903, XP055456424 |
| OPPOSITION | - METAYER, L. E. et al., "Anti-CD47 antibodies induce phagocytosis of live, malignant B cells by macrophages via the Fc domain, resulting in cell death by phagoptosis", Oncotarget, (20170000), vol. 8, no. 37, pages 60892 - 60903, XP055456424 |
| OPPOSITION | - CRUZ et al., Biologics: Targets and Therapy, (20190000), vol. 13, pages 33 - 51, XP55674009 |
| OPPOSITION | - UNO et al., "Antitumor activity of a monoclonal antibody against CD 47 in xenograft models of human leukemia", Oncology Reports, (20070501), vol. 17, no. 5, doi:10.3892/or.17.5.1189, pages 11 89 - 11 94, XP055127957 |
| OPPOSITION | - UNO, S. et al., "Antitumor activity of a monoclonal antibody against CD 47 in xenograft models of human leukemia", Oncology Reports, (20070000), vol. 17, pages 1189 - 1194, XP055127957 |
| OPPOSITION | - DEMEURE et al., "CD47 Engagement Inhibits Cytokine Production and Maturation of Human Dendritic Cells", J Immunol, (20000000), vol. 164, pages 2193 - 2199, XP055674307 |
| OPPOSITION | - AVICE et al., "CD47 Ligation Selectively Inhibits the Development of Human Naive T Cells into Th1 Effectors", J Immunol, (20000000), vol. 165, pages 4624 - 4631, XP055674308 |
| OPPOSITION | - LI et al., "Thrombospondin-1 Inhibits TCR-Mediated T Lymphocyte Early Activation", J Immunol, (20010000), vol. 166, pages 2427 - 2436, XP055674363 |
| OPPOSITION | - AVICE et al., "Role of CD47 in the Induction of Human Naive T Cell Anergy", J Immunol, (20010000), vol. 167, pages 2459 - 2468, XP055674312 |
| OPPOSITION | - MANNA et al., "The mechanism of CD 47-dependent killing of T Cells: heterotrimeric Gi-dependent inhibition of protein kinase A", The Journal of Immunology, (20030401), vol. 170, doi:10.4049/jimmunol.170.7.3544, pages 3544 - 3553, XP055116597 |
| OPPOSITION | - KUROSAKA et al., J. Immunol, (20030000), vol. 171, pages 4672 - 4679, XP55673999 |
| OPPOSITION | - E. M. Van Beek, "Signal Regulatory Proteins in the Immune System", The Journal of Immunology, (20051215), vol. 175, no. 12, doi:10.4049/jimmunol.175.12.7781, ISSN 0022-1767, pages 7781 - 7787, XP055348305 |
| OTHER | - Hayley Rutger, "Students draw a crowd to annual research and community health symposium", Stanford School of Medicine News, (20080520), URL: http://med.stanford.edu/news/all-news/2008/05/students-draw-a-crowd-to-annual-research-and-community-health-symposium.html, XP055532055 |
| OTHER | - PIETSCH et al., "Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies", Blood Cancer J., (20170000), vol. 7, no. 2, page e536, XP055395279 |
| OTHER | - Pietsch et al., "Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies", Blood Cancer Journal, vol. 7, (20170000), XP055395279 |
| OTHER | - Lucy E. Métayer, Anna Vilalta, G.A. Amos Burke, Guy C. Brown, "Anti-CD47 antibodies induce phagocytosis of live, malignant B cells by macrophages via the Fc domain, resulting in cell death by phagoptosis", Oncotarget, vol. 8, no. 37, (20170000), pages 60892 - 60903, XP055456424 |
| SEARCH | - MAJETI RAVINDRA ET AL, "CD47 Is An Independent Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, (20081101), vol. 112, no. 11, ISSN 0006-4971, page 284, XP009160228 [PI] 1-15 * the whole document * |
| SEARCH | - PETTERSEN R F ET AL, "CD47 SIGNALS T CELL DEATH", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, (19990101), vol. 162, ISSN 0022-1767, pages 7031 - 7040, XP002940659 [A] 1-15 * the whole document * |
| SEARCH | [Â ] - RAVINDRA MAJETI1 ET AL, "CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells", DEVELOPMENTAL CELL, CELL PRESS, CAMBRIDGE, MA, US, vol. 138, no. 2, doi:10.1016/J.CELL.2009.05.045, ISSN 1097-4172, (20090723), pages 286 - 299, (20090723), XP002632714 [Â ] * the whole document * |
| SEARCH | [Â ] - JAISWAL S ET AL, "Macrophages as mediators of tumor immunosurveillance", TRENDS IN IMMUNOLOGY, ELSEVIER LTD. * TRENDS JOURNALS, GB, vol. 31, no. 6, doi:10.1016/J.IT.2010.04.001, ISSN 1471-4906, (20100601), pages 212 - 219, (20100601), XP027079216 [Â ] * the whole document * |
| SEARCH | [Â ] - X. W. ZHAO ET AL, "CD47-signal regulatory protein- (SIRP ) interactions form a barrier for antibody-mediated tumor cell destruction", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (20111108), vol. 108, no. 45, doi:10.1073/pnas.1106550108, ISSN 0027-8424, pages 18342 - 18347, XP055055636 [Â ] * Whole document, esp. fig.2 * |
| SEARCH | [Â ] - S. B. WILLINGHAM ET AL, "The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (20120326), vol. 109, no. 17, doi:10.1073/pnas.1121623109, ISSN 0027-8424, pages 6662 - 6667, XP055029983 [Â ] * the whole document * |
| SEARCH | - Y. LIU ET AL, "Signal Regulatory Protein (SIRPalpha ), a Cellular Ligand for CD47, Regulates Neutrophil Transmigration", JOURNAL OF BIOLOGICAL CHEMISTRY, (20020315), vol. 277, no. 12, doi:10.1074/jbc.M109720200, ISSN 0021-9258, pages 10028 - 10036, XP055030073 [A] 1-15 * the whole document * |
| SEARCH | - PARTHA MANNA ET AL, "CD47 mediates killing of breast tumor cells via Gi-dependent inhibition of protein kinase A.", CANCER RESEARCH, (20040201), vol. 64, no. 3, ISSN 0008-5472, pages 1026 - 1036, XP055030076 [X] 1-15 * The whole document, esp. Example 2 * |
| SEARCH | [Â ] - M. P. CHAO ET AL, "Therapeutic Antibody Targeting of CD47 Eliminates Human Acute Lymphoblastic Leukemia", CANCER RESEARCH, (20110215), vol. 71, no. 4, doi:10.1158/0008-5472.CAN-10-2238, ISSN 0008-5472, pages 1374 - 1384, XP055029988 [Â ] * the whole document * |
| SEARCH | [Â ] - X. W. ZHAO ET AL, "Is targeting of CD47-SIRP enough for treating hematopoietic malignancy?", BLOOD, (20120503), vol. 119, no. 18, doi:10.1182/blood-2011-11-391367, ISSN 0006-4971, pages 4333 - 4334, XP055116565 [Â ] * the whole document * |
| SEARCH | - P. P. MANNA ET AL, "The Mechanism of CD47-Dependent Killing of T Cells: Heterotrimeric Gi-Dependent Inhibition of Protein Kinase A", THE JOURNAL OF IMMUNOLOGY, (20030401), vol. 170, no. 7, doi:10.4049/jimmunol.170.7.3544, ISSN 0022-1767, pages 3544 - 3553, XP055116597 [X] 1-15 * the whole document * |
